Dexcel Ltd: BrainQ Raises $40M in Funding

BrainQ, an Israeli stroke therapy technology company, raised $40M in funding. The round was led by Hanaco Ventures, with participation from Dexcel Pharma, and Peregrine Ventures, adding to support already secured from existing investors OurCrowd, Norma, Sailing Capital, IT Farm, Millhouse and Qure. The company intends to use the funds for a multicenter pivotal trial [...] The post BrainQ Raises $40M in Funding appeared first on FinSMEs.